Home DailyMed 1173f15e-ced5-4bbc-be3f-6cec9f38b375 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 01:10:54 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 11 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021540-001 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-002 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-003 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-004 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 5MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-005 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-006 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-007 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 N021540-008 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 10MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD, RS 2004-01-30 N021540-009 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-07-29 N021540-010 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-07-29 N021540-011 CADUET AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM EQ 2.5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-07-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 11 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 12 · 473 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021540-001 CADUET EQ 5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-002 CADUET EQ 5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-003 CADUET EQ 5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-004 CADUET EQ 5MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-005 CADUET EQ 10MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-006 CADUET EQ 10MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-007 CADUET EQ 10MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-008 CADUET EQ 10MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD, RS 2004-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-009 CADUET EQ 2.5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-07-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-010 CADUET EQ 2.5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-07-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021540-011 CADUET EQ 2.5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-07-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021540-001 CADUET EQ 5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-002 CADUET EQ 5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-003 CADUET EQ 5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-004 CADUET EQ 5MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-005 CADUET EQ 10MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-006 CADUET EQ 10MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-007 CADUET EQ 10MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-008 CADUET EQ 10MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD, RS 2004-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-009 CADUET EQ 2.5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-07-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-010 CADUET EQ 2.5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-07-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021540-011 CADUET EQ 2.5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-07-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021540-001 CADUET EQ 5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-002 CADUET EQ 5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-003 CADUET EQ 5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-004 CADUET EQ 5MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-005 CADUET EQ 10MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-006 CADUET EQ 10MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-007 CADUET EQ 10MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-008 CADUET EQ 10MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD, RS 2004-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-009 CADUET EQ 2.5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-07-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-010 CADUET EQ 2.5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-07-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021540-011 CADUET EQ 2.5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-07-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-001 CADUET EQ 5MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-002 CADUET EQ 5MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-003 CADUET EQ 5MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-004 CADUET EQ 5MG BASE;EQ 80MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-005 CADUET EQ 10MG BASE;EQ 10MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-006 CADUET EQ 10MG BASE;EQ 20MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021540-007 CADUET EQ 10MG BASE;EQ 40MG BASE TABLET / ORAL AB RLD 2004-01-30 31067a03dcf5…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 12 · 473 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.